162 related articles for article (PubMed ID: 30319965)
1. Different Response of
Geyer N; Ridzewski R; Bauer J; Kuzyakova M; Dittmann K; Dullin C; Rosenberger A; Schildhaus HU; Uhmann A; Fulda S; Hahn H
Front Oncol; 2018; 8():396. PubMed ID: 30319965
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group.
Pressey JG; Anderson JR; Crossman DK; Lynch JC; Barr FG
Pediatr Blood Cancer; 2011 Dec; 57(6):930-8. PubMed ID: 21618411
[TBL] [Abstract][Full Text] [Related]
3. Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers.
Li QR; Zhao H; Zhang XS; Lang H; Yu K
Acta Pharmacol Sin; 2019 Feb; 40(2):257-267. PubMed ID: 29777201
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog Inhibitors in Rhabdomyosarcoma: A Comparison of Four Compounds and Responsiveness of Four Cell Lines.
Ridzewski R; Rettberg D; Dittmann K; Cuvelier N; Fulda S; Hahn H
Front Oncol; 2015; 5():130. PubMed ID: 26106586
[TBL] [Abstract][Full Text] [Related]
5. Calcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma.
Uhmann A; Niemann H; Lammering B; Henkel C; Heß I; Rosenberger A; Dullin C; Schraepler A; Schulz-Schaeffer W; Hahn H
Sarcoma; 2012; 2012():357040. PubMed ID: 22550417
[TBL] [Abstract][Full Text] [Related]
6. Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance.
Palle K; Mani C; Tripathi K; Athar M
Cancers (Basel); 2015 Nov; 7(4):2330-51. PubMed ID: 26633513
[TBL] [Abstract][Full Text] [Related]
7. Context-dependent modulation of aggressiveness of pediatric tumors by individual oncogenic RAS isoforms.
Bauer J; Cuvelier N; Ragab N; Simon-Keller K; Nitzki F; Geyer N; Botermann DS; Elmer DP; Rosenberger A; Rando TA; Biressi S; Fagin JA; Saur D; Dullin C; Schildhaus HU; Schulz-Schaeffer W; Aberger F; Uhmann A; Hahn H
Oncogene; 2021 Aug; 40(31):4955-4966. PubMed ID: 34172934
[TBL] [Abstract][Full Text] [Related]
8. Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis.
Li Y; Song Q; Day BW
Acta Neuropathol Commun; 2019 Jul; 7(1):123. PubMed ID: 31362788
[TBL] [Abstract][Full Text] [Related]
9. Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice.
Nitzki F; Zibat A; Frommhold A; Schneider A; Schulz-Schaeffer W; Braun T; Hahn H
Oncogene; 2011 Oct; 30(43):4428-36. PubMed ID: 21602886
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.
Nitzki F; Cuvelier N; Dräger J; Schneider A; Braun T; Hahn H
Oncogene; 2016 Jun; 35(22):2923-31. PubMed ID: 26387541
[TBL] [Abstract][Full Text] [Related]
11. Patched1 and Patched2 inhibit Smoothened non-cell autonomously.
Roberts B; Casillas C; Alfaro AC; Jägers C; Roelink H
Elife; 2016 Aug; 5():. PubMed ID: 27552050
[TBL] [Abstract][Full Text] [Related]
12. The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer.
Szczepny A; Rogers S; Jayasekara WSN; Park K; McCloy RA; Cochrane CR; Ganju V; Cooper WA; Sage J; Peacock CD; Cain JE; Burgess A; Watkins DN
Oncogene; 2017 Sep; 36(39):5544-5550. PubMed ID: 28581526
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog related protein expression in breast cancer: gli-2 is associated with poor overall survival.
Im S; Choi HJ; Yoo C; Jung JH; Jeon YW; Suh YJ; Kang CS
Korean J Pathol; 2013 Apr; 47(2):116-23. PubMed ID: 23667370
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog Pathway in Pediatric Cancers: They're Not Just for Brain Tumors Anymore.
Macdonald TJ
Am Soc Clin Oncol Educ Book; 2012; ():605-9. PubMed ID: 24451804
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors.
Pietrobono S; Stecca B
Cells; 2018 Dec; 7(12):. PubMed ID: 30558232
[TBL] [Abstract][Full Text] [Related]
16. Gant61 ameliorates CCl
Jiayuan S; Junyan Y; Xiangzhen W; Zuping L; Jian N; Baowei H; Lifang J
Toxicol Appl Pharmacol; 2020 Jan; 387():114853. PubMed ID: 31816328
[TBL] [Abstract][Full Text] [Related]
17. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
18. The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
Bhateja P; Cherian M; Majumder S; Ramaswamy B
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31394751
[TBL] [Abstract][Full Text] [Related]
19. Activation of hedgehog signaling and its association with cisplatin resistance in ovarian epithelial tumors.
Song X; Yan L; Lu C; Zhang C; Zhu F; Yang J; Jing H; Zhang Y; Qiao J; Guo H
Oncol Lett; 2018 Apr; 15(4):5569-5576. PubMed ID: 29552194
[TBL] [Abstract][Full Text] [Related]
20. L-4, a Well-Tolerated and Orally Active Inhibitor of Hedgehog Pathway, Exhibited Potent Anti-tumor Effects Against Medulloblastoma
Zhu M; Wang H; Wang C; Fang Y; Zhu T; Zhao W; Dong X; Zhang X
Front Pharmacol; 2019; 10():89. PubMed ID: 30846937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
